Related Experiment Video
Updated: Aug 10, 2026
11:45
Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
Partial agonism: mechanisms based on ligand-receptor interactions and on stimulus-response coupling
1Department of Animal Science, ETH-Swiss Federal Institute of Technology, Zürich, Switzerland.
Journal of Receptor and Signal Transduction Research
|March 11, 1999
Summary
Partial agonists produce a lower maximal biological response than standard full agonists. This phenomenon is relative and linked to receptor states and stimulus-response coupling efficacy.
Area of Science:
- Pharmacology
- Biochemistry
- Molecular Biology
Background:
- Partial agonists are defined by their submaximal response compared to a standard full agonist.
- Partial agonism is a relative concept dependent on the reference standard.
- Understanding partial agonism is crucial for drug development and understanding biological signaling.
Purpose of the Study:
- To elucidate the underlying mechanisms of partial agonism.
- To differentiate between receptor-related and stimulus-response coupling mechanisms.
- To explore the relationship between maximal response and EC50 values.
Main Methods:
- Analysis of receptor conformational states and their role in signaling.
- Investigation of agonist-receptor complex dynamics, including stereoisomerism and conformational changes.
- Examination of stimulus-response coupling efficacy and its contribution to partial agonism.
- Correlation analysis of maximal response (E) and EC50 (KE) values ('E, KE plots').
Main Results:
- Partial agonism can arise from multiple receptor conformational states or altered agonist-receptor complex dynamics.
- Steric hindrance during receptor binding can also contribute to partial agonism.
- Stimulus-response coupling efficacy, influenced by receptor state probabilities, plays a key role.
- Linear correlations between maximal response and EC50 are observed in many agonist groups, with 'E, KE plots' offering mechanistic insights.
- Partial agonism shares similarities with responses to irreversibly inhibited receptors.
Conclusions:
- Partial agonism is a complex phenomenon driven by receptor-level and downstream signaling mechanisms.
- The concept of receptor reserve is intrinsically linked to partial agonism.
- 'E, KE plots' provide valuable information for characterizing partial agonists and their mechanisms of action.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...